Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension

Chronobiology International

Volumn 28, Issue 6, 2011, Pages 509-519

  Hermida, Ramón C ^a   Chayán, Luisa ^b   Ayala, Diana E ^a   Mojón, Artemio ^a   Fontao, María J ^a   Fernández, José R ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b Servicio Gallego de Salud   (Spain)

Author keywords

Ambulatory blood pressure monitoring; Chronotherapy; Essential hypertension; Metabolic syndrome; Non dipping

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SLEEP;

EID: 79960982554     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2011.580871     Document Type: Article

References (48)

1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC. (2009). Harmo¬nizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; Amer¬ican Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645.
2. Asmar R, Vol S, Brisac AM, Tichet J, Topouchian J. (2001). Reference values for clinic pulse pressure in a nonselected population. Am. J. Hypertens. 14:415-418. (Pubitemid 32417595)
3. Ayala DE, Hermida RC, Chayán L, Mojón A, Fontao MJ, Fernández JR. (2009). Circadian pattern of ambulatory blood pressure in un¬treated hypertensive patients with an without metabolic syndrome. Chronobiol. Int. 26:1189-1205.
4. Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, Ormezza-no O, Mallion JM, Pépin JL. (2005). Night-time and diastolic hyper¬tension are common and underestimated conditions in newly diagnosed apnoeic patients. J. Hypertens. 23:521-527. (Pubitemid 40684709)
5. Bastos JM, Bertoquini S, Polonia J. (2007). Relationship of circadian blood pressure and morning blood pressure surge with the severity of metabolic syndrome in newly diagnosed hypertensives. Rev. Port. Cardiol. 26:731-741. (Pubitemid 47477437)
6. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hyper¬tension 49:1235-1241. (Pubitemid 46809363)
7. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219-1229. (Pubitemid 47503300)
8. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Al-beriche M, Bonadonna RC, Muggeo M. (1998). Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Dia¬betes 47:1643-1649. (Pubitemid 28445355)
9. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A. (2004a). Metabolic syndrome and target organ damage in untreated essential hypertensives. J. Hypertens. 22:1991-1998. (Pubitemid 39336683)
10. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Sala C, Magrini F, Zanchetti A. (2004b). Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome? Blood Press. 13:230-235. (Pubitemid 39248186)
11. de la Sierra A, RedonJ, Banegas JR, SeguraJ, Parati G, Gorostidi M, dela Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E, Pallarés V, Sarría A, ArandaP,Ruilope LM, Spanish SocietyofHypertension Ambulat¬ory Blood Pressure Monitoring Registry Investigators. (2009). Preva¬lence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 53:466-472.
12. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156-161. (Pubitemid 40946507)
13. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hy¬pertension. Hypertension 51:55-61. (Pubitemid 350307104)
14. Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. (1993). Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am. J. Hypertens. 6:1-7. (Pubitemid 23055797)
15. Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, Damsgaard EM. (2000). Normal blood pressure and preserved diurnal variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome: the Fredericia Study. Diabetes Care 23:283-289. (Pubitemid 30131731)
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752. (Pubitemid 41532612)
17. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. (2011). Pre¬dictive role of the nighttime blood pressure. Hypertension 57:3-10.
18. Hermida RC, Ayala DE. (2009). Chronotherapy with the angiotensin- converting-enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hyperten¬sion 54:40-46.
19. Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007). Influ-enceofmeasurement duration and frequencyonambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131-138. (Pubitemid 46566967)
20. Hermida RC, Ayala DE, Fernández JR, Calvo C. (2008). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69-76. (Pubitemid 350307106)
21. Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2009). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26:61-79.
22. Hermida RC, Ayala DE, Mojon A, Fernandez JR. (2010a). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629-1651.
23. Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010b). Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am. J. Hypertens. 23:432-439.
24. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR. (2010c). Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hyperten¬sion. Chronobiol. Int. 27:560-574.
25. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002). Relation¬ship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097-1104. (Pubitemid 34913627)
26. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taski-nen MR, Groop L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689. (Pubitemid 32893993)
27. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240-245. (Pubitemid 40179967)
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Int. Med. 130:461-470. (Pubitemid 29135798)
29. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. (1995). Left ventricular hyperthrophy in hypertension is associated with insulin-resistance metabolic syndrome. J. Hypertens. 13:433-438.
30. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R. (2007a). Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study. Daily life blood pressure, cardiac damage, and prognosis. Hypertension 49:40-47. (Pubitemid 46360339)
31. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007b). 2007 guidelines for the management of arterial hyper¬tension. The Task Force for the Management of Arterial Hyperten¬sion of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105-1187. (Pubitemid 46924065)
32. Mansoor GA, White WB, McCabe EJ, Giacco S. (2000). The relationship of electronically monitored physical activity toblood pressure, heart rate, and the circadian blood pressure profile. Am. J. Hypertens. 13:262-267. (Pubitemid 30206948)
33. Mochizuki Y, Okutani M, Donfeng Y, Iwasaki H, Takusagawa M, Kohno I, Mochizuki S, Umetani K, Ishii H, Ijiri H, Komori S, Tamura K. (1998). Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am. J. Hypertens. 11:403-409. (Pubitemid 28231451)
34. Mulè G, Cottone S, Mongiovi R, Cusimano P, Mezzatesta G, Seddio G, Volpe V, Nardi E, Andronico G, Piazza G, Cerasola G. (2006). Influ¬ence of metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr. Metab. Cardiovasc. Dis. 16:54-59.
35. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, Giandalia ME, Mezzatesta G, Andronico G, Cerasola G. (2007). Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension. Am. J. Hypertens. 20:197-203. (Pubitemid 46157264)
36. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the noc¬turnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183-2189. (Pubitemid 35388236)
37. Palaniappan L, Carnethon M, Fortman SP. (2003). Association between microalbuminuria and the metabolic syndrome: NHANES III. Am. J. Hypertens. 16:952-958. (Pubitemid 37315495)
38. Portaluppi F, Smolensky MH. (2010). Perspectives on the chronother-apy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652-1667.
39. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
40. Rantala AO, KaumaH,Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. (1999). Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245:163-174. (Pubitemid 29089113)
41. Ridker PM, Buring JE, Cook NR, Rifai N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397.
42. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. (2004). Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 43:1817-1822. (Pubitemid 38622521)
43. Schillaci G, Pirro M, Vaudo G, Mannarino MR, Savarese G, Pucci G, Franklin SS, Mannarino E. (2005). Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45:1078-1082. (Pubitemid 40770308)
44. Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, Vaudo G, Mannarino E. (2006). Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 47:881-886. (Pubitemid 44297559)
45. Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173-180.
46. Tartan Z, Uyarel H, Kasikcioglu H, Alper AT, Ozay B, Bilsen T, Gul M, Ozturk R, Cam N. (2006). Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J. Exp. Med. 210:57-66. (Pubitemid 44377790)
47. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. (1998). Ambulatory pulse pressure: a potent predictor of total car¬diovascular risk in hypertension. Hypertension 32:983-988. (Pubitemid 29001424)
48. Vyssoulis GP, Karpanou EA, Kyvelou SMG, Adamopoulos DN, Deli-georgis AD, Spanos PG, Pietri PG, Cokkinos DF, Stefanadis CI. (2007). Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients. Blood Press. Monit. 12:351-356. (Pubitemid 351339496)